Actinogen Limited

ASX:ACW ISIN:AU000000ACW3

 
 

News

Biotech Investors Move Ahead on the Learning Curve

🕔6/11/2015 3:13:43 PM 13630

Australian and New Zealand biotech investors are set to hear from a top line up of speakers from ASX-listed life science companies, as well as several private firms and international businesses, in July, at the 11th Bioshares Biotech Summit.

Read Full Article▸
###

1,996 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 6) (Last 30 Days: 30) (Since Published: 1996) 

Company Data

More News Results

  • 2025/10/23: ACW September 2025 quarterly activity report & Appendix 4C*
  • 2025/10/20: ACW confirms eligibility for further $1.9m RDTI*
  • 2025/10/20: ACW achieves early screening closure for XanaMIA trial*
  • 2025/10/15: Annual Report to Shareholders*
  • 2025/10/15: Letter to Shareholders, Notice of AGM & Proxy Form*
  • 2025/10/15: ACW receives initial $5.5m R&D tax incentive rebate*
  • 2025/09/30: AGM Date & Closing Date for Director Nominations*
  • 2025/09/29: Notification of cessation of securities - ACW*
  • 2025/09/15: ACW successful FDA meeting on Alzheimers program*
  • 2025/09/11: ACW launches InvestorHub portal to boost investor engagement*
*refer to company website